Ena Respiratory

Developer of antiviral host defense enhancers for respiratory infections. It develops first-in-class prophylactics that prime and boost the body's natural defenses against viral respiratory infections. These enhancers ha

placeMelbourne, Victoria, Australia calendar_todayFounded 2020 groups9 employees language enarespiratory.com

Social engagement

Social engagement: 1.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Uniseed, Minderoo Foundation, Brandon Capital.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%

Recent activity

18 Jun 2026
Event
BIO International Convention 2026
15 Jun 2026
Milestone
regulatory
14 May 2026
Event
American Thoracic Society Conference
Coming soon